Spots Global Cancer Trial Database for Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

Official Title: Analysis of Swallowing, Speech and Quality of Life of Patients With Stage T3-T4 Squamous Cell Carcinoma of the Oropharynx Before and After Multimodal Treatment With Curative Intent

Study ID: NCT02552550

Conditions

Squamous Cell Carcinoma of the Oropharynx

Interventions

Ability to swallow, speak and quality of life

Study Description

Brief Summary: The curative treatment and organ preservation in advanced squamous cell carcinoma of the oropharynx is multimodal. It involves induction chemotherapy and depending on the response radio-chemotherapy or surgery. The combination of these methods has important functional consequences. The aim of this prospective pilot study is to describe swallowing, speech, but also patients' quality of life before and after therapeutic management (existing studies measuring these functions after treatment but not before).

Detailed Description: This study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak then, as in normal practice, after 3, 6 and 12 months after treatment.